Home

Case Study

Leveraging Machine Learning to Optimize Care for Patients with Type 2 Diabetes and Obesity

Leveraging Machine Learning to Optimize Care for Patients with Type 2 Diabetes and Obesity

IQVIA
Pages 2 Pages

A pharma company preparing for approval of a dual-action diabetes/obesity drug needed to identify patients with unmet needs and their providers. IQVIA configured ML apps in just three weeks, creating patient cohorts and market definitions from claims data. The tool revealed relevant HCPs, supported tailored outreach, and enabled continuous updates. Tight deadlines were met, and the client achieved precise targeting to facilitate optimal care and engagement.

Join for free to read

You Might Also Like


AD COUNCIL’S TYPE 2 DIABETES PREVENTION
Case Study AD COUNCIL’S TYPE 2 DIABETES PREVENTION
AdTheorent

Case Study: Automotive Group Sees Increased Engagement with a Type 2 Diabetes-specific Health Plan
Case Study Case Study: Automotive Group Sees Increased Engagement with a…
United Health Care Group

Continuous CI monitoring in type 2 diabetes
Case Study Continuous CI monitoring in type 2 diabetes
Course5

Pediatric Type I Diabetes Mellitus
Case Study Pediatric Type I Diabetes Mellitus
Makrocare

More from IQVIA


Predicting Misdiagnosed Adult-Onset Type 1 Diabetes Using Machine Learning
Case Study Predicting Misdiagnosed Adult-Onset Type 1 Diabetes Using…
IQVIA

USING AI & MACHINE LEARNING TO DRIVE COMMERCIAL SUCCESS IN THE EU
White Paper USING AI & MACHINE LEARNING TO DRIVE COMMERCIAL SUCCESS IN THE EU
IQVIA

Predicting future cost burden of patients with type 2 diabetes mellitus in the US and Europe
Case Study Predicting future cost burden of patients with type 2 diabetes…
IQVIA

RWE OMOP results showed that emerging therapy was just as effective as traditional type 2 diabetes treatment
Case Study RWE OMOP results showed that emerging therapy was just as…
IQVIA
© 2025 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info